Catalyst Funds Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
NAMA
Catalyst Funds Management's CDNA Position: Q4 2024 in Review
Catalyst Funds Management sold out of CareDx (CDNA) in Q4 2024, closing a stake of 5,000 shares — an estimated $156K sold.
Catalyst Funds Management first reported a position in CDNA in Q1 2024 and held it in 3 quarters. The position peaked at $156K in Q3 2024. 210 funds tracked by Wall St. Rank hold CDNA as of Q4 2024.
- Catalyst Funds Management reported no remaining CareDx position as of Q4 2024 after selling out during the quarter.
- Catalyst Funds Management sold 5,000 CareDx shares in Q4 2024, an estimated $156K.
- Catalyst Funds Management first reported a position in CareDx in Q1 2024 and held it in 3 quarters.
- Catalyst Funds Management's CareDx position peaked at $156K in Q3 2024.
- 210 funds tracked by Wall St. Rank held CareDx as of Q4 2024.
Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.